Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Csernok

Showing results (81-90 of 107) with videos related to

Pageof 11
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1995
Distribution of the granulocyte serine proteinases proteinase 3 and elastase in human glomerulonephritisC Mrowka, E Csernok, W L Gross, et al.
Arthritis and Rheumatism|March 20, 1998
Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damageW H Schmitt, E Csernok, S Kobayashi, et al.
Annals of the Rheumatic Diseases|January 29, 2010
Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis?K Laskari, K Laskaria, K Ahmadi-Simab, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1997
[Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases]A Schnabel, E Csernok, H Schultz, et al.
Clinical and Experimental Immunology|October 27, 2001
Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosisK Steiner, F Moosig, E Csernok, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
In vitro interactions of c-ANCA (antibodies to proteinase 3) with human endothelial cellsW J Mayet, E M Hermann, E Csernok, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1994
Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIaA J Porges, P B Redecha, W T Kimberly, et al.
Clinical and Experimental Immunology|May 2, 2002
Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapyP Lamprecht, G Kumanovics, A Mueller, et al.
The Journal of Experimental Medicine|October 1, 1996
Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generationF Grimminger, K Hattar, C Papavassilis, et al.
Arthritis and Rheumatism|April 22, 1999
Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammationE Csernok, A Trabandt, A Müller, et al.
Pageof 11

Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1995
Distribution of the granulocyte serine proteinases proteinase 3 and elastase in human glomerulonephritisC Mrowka, E Csernok, W L Gross, et al.
Arthritis and Rheumatism|March 20, 1998
Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damageW H Schmitt, E Csernok, S Kobayashi, et al.
Annals of the Rheumatic Diseases|January 29, 2010
Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis?K Laskari, K Laskaria, K Ahmadi-Simab, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 15, 1997
[Bactericidal permeability increasing protein (BPI-ANCA marked chronic inflammatory bowel diseases and hepatobiliary diseases]A Schnabel, E Csernok, H Schultz, et al.
Clinical and Experimental Immunology|October 27, 2001
Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosisK Steiner, F Moosig, E Csernok, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
In vitro interactions of c-ANCA (antibodies to proteinase 3) with human endothelial cellsW J Mayet, E M Hermann, E Csernok, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1994
Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIaA J Porges, P B Redecha, W T Kimberly, et al.
Clinical and Experimental Immunology|May 2, 2002
Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapyP Lamprecht, G Kumanovics, A Mueller, et al.
The Journal of Experimental Medicine|October 1, 1996
Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generationF Grimminger, K Hattar, C Papavassilis, et al.
Arthritis and Rheumatism|April 22, 1999
Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammationE Csernok, A Trabandt, A Müller, et al.
Pageof 11